Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The EZH2–PHACTR2–AS1–Ribosome Axis induces Genomic Instability and Promotes Growth and Metastasis in Breast Cancer
Wenhui Chu, Xi Zhang, Lihua Qi, et al.
Cancer Research (2020) Vol. 80, Iss. 13, pp. 2737-2750
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
Amr R. Elhamamsy, Brandon J. Metge, Heba Allah Alsheikh, et al.
Cancer Research (2022) Vol. 82, Iss. 13, pp. 2344-2353
Open Access | Times Cited: 178
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 138
Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis
Irina V. Bure, М. В. Немцова, Ekaterina Kuznetsova
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5801-5801
Open Access | Times Cited: 99
New clinical trial design in precision medicine: discovery, development and direction
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
ACS Combinatorial Science (2020) Vol. 22, Iss. 12, pp. 669-700
Open Access | Times Cited: 86
lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
Xin Jin, Wei Du, Wentao Huang, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 613-637
Open Access | Times Cited: 81
Progress of Breast Cancer basic research in China
Xuerong Wang, Chao Wang, Jiaheng Guan, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 8, pp. 2069-2079
Open Access | Times Cited: 75
The DNMT1-PAS1-PH20 axis drives breast cancer growth and metastasis
Yenan Fu, Xi Zhang, Xiao Liu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 39
The roles of epigenetics in cancer progression and metastasis
Jocelyn F. Chen, Qin Yan
Biochemical Journal (2021) Vol. 478, Iss. 17, pp. 3373-3393
Open Access | Times Cited: 56
CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition
Xianxiong Ma, Hengyu Chen, Lei Li, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 43
Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus
Zeina Nehme, Sébastien Pasquereau, Sandy Haidar Ahmad, et al.
EBioMedicine (2022) Vol. 80, pp. 104056-104056
Open Access | Times Cited: 35
LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis
Jin Hu, Haohao Huang, Zihan Xi, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 35
Managing therapeutic resistance in breast cancer: from the lncRNAs perspective
Liyuan Peng, Jingwen Jiang, Bo Tang, et al.
Theranostics (2020) Vol. 10, Iss. 23, pp. 10360-10377
Open Access | Times Cited: 41
EZH1/2 as targets for cancer therapy
Ran An, Yuqing Li, Yue-Ling Lin, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 2, pp. 221-235
Closed Access | Times Cited: 26
LncRNAs and the Cancer Epigenome: Mechanisms and Therapeutic Potential
Revathy Nadhan, Ciro Isidoro, Yong Sang Song, et al.
Cancer Letters (2024) Vol. 605, pp. 217297-217297
Closed Access | Times Cited: 5
The pharmacological and biological importance of EZH2 signaling in lung cancer
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114313-114313
Open Access | Times Cited: 13
PCAF-mediated acetylation of METTL3 impairs mRNA translation efficiency in response to oxidative stress
Cheng Liu, Miao Yu, Mengyuan Wang, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2157-2168
Closed Access | Times Cited: 4
Genetic association between human skin microbiota with vaginitis: a two-sample Mendelian randomization study
Yuxue Zhang, Huihui Chen, Yi‐Ming Shi, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression
Yongsheng Zhang, Yanjiao Xu, Yanping Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Crosstalk between Methylation and ncRNAs in Breast Cancer: Therapeutic and Diagnostic Implications
Yitong Liu, Ping Leng, Yan Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15759-15759
Open Access | Times Cited: 16
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9
ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
Xuan Cheng, Jianxiong Zhao, Feng Dong, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19
The role of lncRNAs and exosomal lncRNAs in cancer metastasis
Yutong Zhang, Lijuan Zhao, Ya‐Ping Bi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115207-115207
Open Access | Times Cited: 8
RETRACTED ARTICLE: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
Tangwei Wu, Xiaoyi Li, Yan Ge, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 7
SPOCK2 and SPRED1 function downstream of EZH2 to impede the malignant progression of lung adenocarcinoma in vitro and in vivo
Yang Liu, Xiaoxi Fan, Changrui Jiang, et al.
Human Cell (2023) Vol. 36, Iss. 2, pp. 812-821
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top